Interaction between antipyrine and aminopyrine

Area of Science:

• Pharmacology
• Drug Metabolism
• Toxicology

Background:

• Aminopyrine and antipyrine are commonly used drugs.
• Understanding their metabolic interactions is crucial for safe and effective drug therapy.
• Hepatic drug oxidation pathways are key targets for drug-drug interactions.

Purpose of the Study:

• To investigate the effect of aminopyrine on antipyrine disposition in humans.
• To elucidate the in vitro mechanism of interaction between aminopyrine and antipyrine using animal models.
• To determine the optimal timing for administering these drugs for pharmacokinetic studies.

Main Methods:

• Human volunteers received oral doses of aminopyrine and antipyrine.
• Plasma half-life and metabolic clearance of antipyrine were measured.
• In vitro studies using hepatic microsomes from rats, mice, and dogs assessed drug hydroxylation and N-demethylation rates.

Main Results:

• Aminopyrine significantly prolonged antipyrine's plasma half-life and reduced its metabolic clearance.
• Antipyrine did not alter aminopyrine disposition when given simultaneously.
• 4-aminoantipyrine showed mixed-type inhibition of antipyrine hydroxylation in vitro; antipyrine competitively inhibited aminopyrine N-demethylation.

Conclusions:

• Simultaneous administration of aminopyrine and antipyrine can interfere with pharmacokinetic studies of hepatic drug oxidation.
• Aminopyrine's metabolite, 4-aminoantipyrine, likely plays a role in the observed drug interactions.
• A 24-hour interval between administrations is suggested for accurate drug metabolism assessments.